Over-ambitious doctors seem to have prompted Abiomed Inc. (NASDAQ:ABMD) to close down a clinical trial of its flagship cardiac assist device. The Danvers, Massachusetts-based company pulled the plug ...
Abiomed Inc., has worked the ventricular assist device (VAD) space for a number of years with its Impella series of VADs, and a study coming out of Japan seems to affirm investors’ confidence in these ... BioWorld: Abiomed’s Impella devices show well in Japanese study of cardiogenic shock Kiii3 News: New device in use at Spohn Shoreline helps take load off patients' hearts recover from cardiac episodes CORPUS CHRISTI, Texas — A new life-saving technology is now at Christus Spohn Hospital Shoreline, making them the first hospital in South Texas to offer an Impella RP with Smart Assist heart-pump ... New device in use at Spohn Shoreline helps take load off patients' hearts recover from cardiac episodes Hackensack Meridian Health, Hackensack University Medical Center cardiac surgeon Yuriy Dudiy, M.D. became the second in the world to successfully implant the Impella Bridge-to-Recovery (BTR)™ heart ...
impella cardiac assist device, For Abiomed’s beleaguered family of Impella heart pumps, Class I recalls are becoming a monthly event. The devices have racked up their third recall in as many months, the latest of which focuses on ...
